Drug Price Competition and Patent Term Restoration Act
The Drug Price Competition and Patent Term Restoration Act (Public Law 98-417), informally known as the Hatch-Waxman Act, is a 1984 United States federal law which encourages the manufacture of generic drugs by the pharmaceutical industry and established the modern system of government generic drug regulation in the United States. Representative Henry Waxman of California and Senator Orrin Hatch of Utah sponsored the act.
LawsApplied
Drug Price Competition and Patent Term Restoration Act
The Drug Price Competition and Patent Term Restoration Act (Public Law 98-417), informally known as the Hatch-Waxman Act, is a 1984 United States federal law which encourages the manufacture of generic drugs by the pharmaceutical industry and established the modern system of government generic drug regulation in the United States. Representative Henry Waxman of California and Senator Orrin Hatch of Utah sponsored the act.
has abstract
The Drug Price Competition and ...... tch of Utah sponsored the act.
@en
Link from a Wikipage to an external page
Wikipage page ID
Wikipage revision ID
742,640,204
acronym
Hatch-Waxman amendments
acts amended
cite public law
conferencedate
1984-09-06
effective date
1984-09-24
enacted by
introducedby
Charles McC. Mathias, Jr.
introduceddate
1983-06-23
introducedin
leghisturl
longtitle
An Act to amend the Federal Fo ...... ducts, and for other purposes.
passedbody
passeddate
1984-06-29
1984-09-06
1984-09-12
1984-09-19
passedvote
voice vote agreed
voice vote agreed, with amendments
public law url
sections amended
Chapter 9 § 301 et seq.
shorttitle
Drug Price Competition and Patent Term Restoration Act
signeddate
1984-09-24
signedpresident
title amended
subject
hypernym
comment
The Drug Price Competition and ...... tch of Utah sponsored the act.
@en
label
Drug Price Competition and Patent Term Restoration Act
@en